Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs-Reference-Cited by-同舟云学术

Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs

Published:2021-05-29 Issue:10 Volume:40 Page:4309-4315
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Yousefghahari Behnaz^ORCID,Navari Sanaz,Sadeghi Mahmoud,Soleimaniamiri Shima,Soleimaniamiri Mohammadjafar,Heidari Behzad,Babaei Mansour,Ghodrati Kian,Guran Ardeshir,Gholinia Hemmat

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-021-05779-4.pdf

Reference35 articles.

1. Shah K, Saxena D, Mavalankar D (2020) Secondary attack rate of COVID-19 in household contacts: a systematic review. QJM 113(12):841–850. https://doi.org/10.1093/qjmed/hcaa232

2. Tobaiqy M, Qashqary M, Al-Dahery S, Mujallad A, Hershan AA, Kamal MA, Helmi N (2020) Therapeutic management of patients with COVID-19: a systematic review. Infection Prevention in Practice 2(3):100061. https://doi.org/10.1016/j.infpip.2020.100061

3. Gentile I, Maraolo AE, Piscitelli P, Colao A (2020) COVID-19: time for post-exposure prophylaxis? Int J Environ Res Public Health 17(11):3997. https://doi.org/10.3390/ijerph17113997

4. Ip A, Ahn J, Zhou Y, et al. Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study. MedRxiv. 2020. https://doi.org/10.1101/2020.08.20.20178772

5. Peiris M, Leung GM (2020) What can we expect from first-generation COVID-19 vaccines? Lancet 396(10261):1467–1469. https://doi.org/10.1016/S0140-6736(20)31976-0

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of related factors for RA flares after SARS-CoV-2 infection: a retrospective study from patient survey;Scientific Reports;2024-02-20

2. Prevalence and Risk Factors of COVID-19 Reinfection in Patients with Rheumatoid Arthritis: A Retrospective Observational Study;Yonsei Medical Journal;2024

3. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey;Rheumatology International;2023-10-31

4. Frequency and course of COVID-19 in patients with rheumatic diseases (according to the data of V.A. Nasonova Research Institute of Rheumatology);Rheumatology Science and Practice;2023-10-27

5. Effects of the COVID-19 Pandemic in Unvaccinated Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients Using Disease-modifying Antirheumatic Drugs;Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy;2023-06-23